Citigroup Maintains Buy Rating for BeiGene: Here's What You Need To Know
Portfolio Pulse from Benzinga Insights
Citigroup has maintained its Buy rating for BeiGene (NASDAQ:BGNE) and increased its price target from $285.00 to $290.00. Despite this, BeiGene's shares have fallen by 2.84% over the last 24 hours, currently trading at $187.37 per share. A move to $290.00 would represent a 54.77% increase from the current share price.
September 21, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Citigroup's maintained Buy rating and increased price target for BeiGene could potentially boost investor confidence, despite the recent 2.84% drop in share price.
Analyst ratings and price targets can significantly influence investor sentiment and stock price movements. Citigroup's decision to maintain a Buy rating and raise the price target for BeiGene suggests a positive outlook for the company, which could potentially offset the recent drop in share price and drive a price increase in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100